What is Tasso?
Tasso's core mission is to enhance patient experience and improve health outcomes by making diagnostic testing accessible at home. The company aims to empower individuals to make more informed healthcare decisions, thereby improving their overall quality of life. This strategic focus positions Tasso at the intersection of healthcare innovation and consumer convenience, addressing a growing demand for personalized and accessible medical solutions. The company's commitment to advancing home diagnostics is a key driver of its market presence.
How much funding has Tasso raised?
Tasso has raised a total of $125.4M across 4 funding rounds:
Grant
$2.3M
Other Financing Round
$6.1M
Series A
$17M
Series B
$100M
Grant (2014): $2.3M, investors not publicly disclosed
Other Financing Round (2019): $6.1M led by Vertical Venture Partners
Series A (2020): $17M, investors not publicly disclosed
Series B (2021): $100M featuring InCube, D. E. SHAW, Senvest Capital, RA Capital Management, and SVB Innovation Fund
Key Investors in Tasso
Senvest Capital
Senvest Capital, established in 1968 and based in Montreal, Canada, is a holding company with a diversified investment portfolio, including interests in investment management and direct investments in both public and private securities.
D. E. SHAW
D. E. Shaw, founded in 1988, is a prominent asset management firm headquartered in New York, specializing in quantitative investing strategies.
Vertical Venture Partners
Vertical Venture Partners is an investment firm that likely focuses on innovative companies, as indicated by its name and participation in Tasso's funding rounds.
What's next for Tasso?
With the recent influx of major strategic investment, Tasso is poised for accelerated growth and further innovation in its diagnostic solutions. The substantial capital infusion is expected to fuel advancements in product development, expand market reach, and enhance operational capabilities. This strategic backing suggests a strong confidence from investors in Tasso's vision and its potential to disrupt the traditional healthcare landscape by bringing critical diagnostic tools directly to consumers. The company's next steps will likely involve scaling its operations and solidifying its position as a leader in the home healthcare technology market.
See full Tasso company page
